Patricia Soulard

Patricia Soulard has extensive experience in the pharmaceutical industry. Patricia is currently the Executive Director Translational Medicine Head at Rgenta Therapeutics Inc. Prior to this, they worked at Merck KGaA, Darmstadt, Germany, where they held various roles including Director & Translational Biomarker Research Lead of Clinical Immunotherapies and Scientific and Strategic Consultant - Immuno-Oncology Portfolio Strategies Management. Patricia has also worked at FORMA Therapeutics as Director, Discovery & Translational Biology, and at Duo BioPharma as the Founder and Executive Director of Biology. Earlier in their career, they were a Senior Research and Development Strategic Consultant at Aileron Therapeutics, a Scientific Co-Founder and Consultant at Catabasis Pharmaceuticals, and a Research Fellow and Worldwide Head of the Pfizer Drug Pfinder Program at Pfizer Pharmaceuticals. Patricia began their career at Parke-Davis as an Associate Scientist before progressing to the role of Scientist. Throughout their career, Patricia has demonstrated expertise in drug discovery and development, strategic consulting, and scientific leadership.

Patricia Soulard earned their Master's Degree in Biology from the Conservatoire National des Arts et Métiers. Patricia attended the institution from 1992 to 1994.